Citation: P. Bucsky et Rm. Egeler, MALIGNANT HISTIOCYTIC DISORDERS IN CHILDREN - CLINICAL AND THERAPEUTIC APPROACHES WITH A NOSOLOGIC DISCUSSION, Hematology/oncology clinics of North America, 12(2), 1998, pp. 465
Authors:
WAGNER HJ
KLINTWORTH F
JABS W
LANGE K
SCHLEGELBERGER B
HARDER L
FELLER AC
BUCSKY P
Citation: Hj. Wagner et al., CHARACTERIZATION OF THE NOVEL, PEDIATRIC HODGKIN-DISEASE-DERIVED CELL-LINE HKB-1, Medical and pediatric oncology, 31(3), 1998, pp. 138-143
Authors:
SCHULTZ C
KLOUCHE M
FRIEDRICHSDORF S
RICHTER N
KROEHNERT B
BUCSKY P
Citation: C. Schultz et al., LANGERHANS CELL HISTIOCYTOSIS IN CHILDREN - DOES SOLUBLE INTERLEUKIN-2-RECEPTOR CORRELATE WITH BOTH DISEASE EXTENT AND ACTIVITY, Medical and pediatric oncology, 31(2), 1998, pp. 61-65
Citation: P. Bucsky et T. Parlowsky, EPIDEMIOLOGY AND THERAPY OF THYROID-CANCER IN CHILDHOOD AND ADOLESCENCE, EXPERIMENTAL AND CLINICAL ENDOCRINOLOGY & DIABETES, 105, 1997, pp. 70-73
Authors:
FARAHATI J
BUCSKY P
PARLOWSKI T
MADER U
REINERS C
Citation: J. Farahati et al., CHARACTERISTICS OF DIFFERENTIATED THYROID-CANCER IN CHILDREN AND ADOLESCENTS WITH RESPECT TO AGE, SEX AND HISTOLOGY, The Journal of nuclear medicine, 38(5), 1997, pp. 1120-1120
Authors:
FAVARA BE
FELLER AC
PAULI M
JAFFE ES
WEISS LM
ARICO M
BUCSKY P
EGELER RM
ELINDER G
GADNER H
GRESIK M
HENTER JI
IMASHUKU S
JANKASCHAUB G
JAFFE R
LADISCH S
NEZELOF C
PRITCHARD J
Citation: Be. Favara et al., CONTEMPORARY CLASSIFICATION OF HISTIOCYTIC DISORDERS, Medical and pediatric oncology, 29(3), 1997, pp. 157-166
Authors:
FARAHATI J
BUCSKY P
PARLOWSKY T
MADER U
REINERS C
Citation: J. Farahati et al., CHARACTERISTICS OF DIFFERENTIATED THYROID-CARCINOMA IN CHILDREN AND ADOLESCENTS WITH RESPECT TO AGE, GENDER, AND HISTOLOGY, Cancer, 80(11), 1997, pp. 2156-2162
Authors:
WIEDEMANN GJ
ROBINS HI
KATSCHINSKI DM
MENTZEL M
VANHEEK R
TOUHIDI RR
BUCSKY P
GILLIS W
FEYERABEND T
DOLEIRE F
FREUND C
ELEFTHERIADIS S
WEISS C
WAGNER T
Citation: Gj. Wiedemann et al., CLINICAL-TRIALS ON THE COMBINATION OF IFO SFAMIDE, CARBOPLATIN AND ETOPOSIDE (ICE) WITH WHOLE-BODY HYPERTHERMIA, Medizinische Klinik, 91(5), 1996, pp. 279-283
Authors:
LINK H
DIEDRICH H
ARSENIEV L
STOLL M
EBELL W
FREUND M
TISCHLER J
CASPER J
HUBNER G
SCHOFFSKI P
DIEHL S
GOES A
JACOBS R
KADAR J
STANGEL W
MULLER R
RITTMANN KL
WILDFANG I
BUCSKY P
BETTONI C
SCHMIDT RE
RIEHM H
POLIWODA H
Citation: H. Link et al., 10 YEARS TRANSPLANTATION OF BONE-MARROW A ND OF HEMATOPOIETIC STEM-CELLS AT THE MEDICAL-SCHOOL HANOVER, Medizinische Klinik, 91, 1996, pp. 3-17
Citation: T. Parlowsky et al., MALIGNANT ENDOCRINE TUMORS IN CHILDHOOD AND ADOLESCENCE - RESULTS OF A RETROSPECTIVE ANALYSIS, Klinische Padiatrie, 208(4), 1996, pp. 205-209
Authors:
WAGNER HJ
KLUTER H
KRUSE A
BUCSKY P
HORNEF M
KIRCHNER H
Citation: Hj. Wagner et al., DETERMINATION OF THE NUMBER OF EPSTEIN-BARR-VIRUS GENOMES IN WHOLE-BLOOD AND RED-CELL CONCENTRATES, TRANSFUSION MEDICINE, 5(4), 1995, pp. 297-302
Citation: C. Nezelof et al., MALIGNANT HISTIOCYTOSIS IN CHILDHOOD - A DISEASE IN QUEST OF NEW NOSOLOGICAL CRITERIA, Medical and pediatric oncology, 25(2), 1995, pp. 67-69
Authors:
REITER A
SCHRAPPE M
TIEMANN M
PARWARESCH R
ZIMMERMANN M
YAKISAN E
DOPFER R
BUCSKY P
MANN G
GADNER H
RIEHM H
Citation: A. Reiter et al., SUCCESSFUL TREATMENT STRATEGY FOR KI-1 ANAPLASTIC LARGE-CELL LYMPHOMAOF CHILDHOOD - A PROSPECTIVE ANALYSIS OF 62 PATIENTS ENROLLED IN 3 CONSECUTIVE BERLIN-FRANKFURT-MUNSTER GROUP STUDIES, Journal of clinical oncology, 12(5), 1994, pp. 899-908
Authors:
BUCSKY P
FAVARA B
FELLER AC
NEZELOF C
RADZUN HJ
SCHLEGELBERGER B
JANKASCHAUB G
Citation: P. Bucsky et al., MALIGNANT HISTIOCYTOSIS AND LARGE-CELL ANAPLASTIC (KI-1) LYMPHOMA IN CHILDHOOD - GUIDELINES FOR DIFFERENTIAL-DIAGNOSIS - REPORT OF THE HISTIOCYTE SOCIETY, Medical and pediatric oncology, 22(3), 1994, pp. 200-203
Authors:
WIEDEMANN GJ
DOLEIRE F
KNOP E
EIEFTHERIADIS S
BUCSKY P
FEDDERSEN S
KLOUCHE M
GEISLER J
MENTZEL M
SCHMUCKER P
FEYERABEND T
WEISS C
WAGNER T
Citation: Gj. Wiedemann et al., IFOSFAMIDE AND CARBOPLATIN COMBINED WITH 41.8-DEGREES-C WHOLE-BODY HYPERTHERMIA IN PATIENTS WITH REFRACTORY SARCOMA AND MALIGNANT TERATOMA, Cancer research, 54(20), 1994, pp. 5346-5350